Answers are grounded in this paper and cite their sources.
Rifaximin inhibits a broad spectrum of bacteria in the bile-rich small bowel and susceptible bacteria in the aqueous colon, and alters microbial virulence and epithelial cell function. The different mechanisms of action of rifaximin potentially explain the use of the drug in widely varied diseases and syndromes.
No takes yet. Share an insight, caveat, or question.
Herbert L. DuPont (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: